Form 4: Kura Oncology COO Sells Shares
Insider Transaction (Form 4)
Kathleen Ford, Chief Operating Officer of Kura Oncology, Inc., sold 10,574 shares of common stock on September 28, 2026.
Summary
- Open-market sale: disposed of 6,906 Common Stock at $10.50 ($72,494) on September 28, 2026; holds 146,654 after (Direct).
- Open-market sale: disposed of 3,668 Common Stock at $10.75 ($39,437) on September 29, 2026; holds 142,986 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $111,931 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kathleen Ford — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Common Stock | 6,906 | $10 | $72.5K | 146,654 |
| 2026-09-29 | Open-market sale | Common Stock | 3,668 | $11 | $39.4K | 142,986 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (6,906 shares) |
| 2026-09-29 | Open-market sale (3,668 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bearish, Kathleen Ford
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.